Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Priralfinamide

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Ralfinamide, 133865-88-0, (s)-2-((4-((2-fluorobenzyl)oxy)benzyl)amino)propanamide, Priralfinamide [inn], Nw-1029, (2s)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide
    Molecular Formula
    C17H19FN2O2
    Molecular Weight
    302.34  g/mol
    InChI Key
    BHJIBOFHEFDSAU-LBPRGKRZSA-N
    FDA UNII
    3LPF0S0GVV
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide
    2.1.2 InChI
    InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1
    2.1.3 InChI Key
    BHJIBOFHEFDSAU-LBPRGKRZSA-N
    2.1.4 Canonical SMILES
    CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC=CC=C2F
    2.1.5 Isomeric SMILES
    C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC=CC=C2F
    2.2 Other Identifiers
    2.2.1 UNII
    3LPF0S0GVV
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2-(((4-((2-fluorophenyl)methoxy)phenyl)methyl)amino)propanamide

    2. Ralfinamide

    2.3.2 Depositor-Supplied Synonyms

    1. Ralfinamide

    2. 133865-88-0

    3. (s)-2-((4-((2-fluorobenzyl)oxy)benzyl)amino)propanamide

    4. Priralfinamide [inn]

    5. Nw-1029

    6. (2s)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide

    7. (2s)-2-(4-(2-fluorobenzyloxy)benzylamino)propanamide

    8. 3lpf0s0gvv

    9. Ralfinamida

    10. Pnu-0154339e

    11. Fce-26742a

    12. Ralfinamida [inn-spanish]

    13. Unii-3lpf0s0gvv

    14. (s)-2-(4-(2-fluorobenzyloxy)benzylamino)propanamide

    15. (s)-2-[4-(2-fluorobenzyloxy)benzylamino]propanamide

    16. (s)-2-[[4-[(2-fluorobenzyl)oxy]benzyl]amino]propanamide

    17. Schembl67328

    18. Chembl2107771

    19. Dtxsid70158406

    20. Bdbm161094

    21. Mfcd08272558

    22. Zinc72190123

    23. Akos016006629

    24. Db06649

    25. Ncgc00370789-01

    26. Ds-18607

    27. Hy-101437

    28. Cs-0021330

    29. F12108

    30. A888008

    31. (s)-2-[4-(2-fluorobenzyloxy) Benzylamino]propanamide

    32. Q21098885

    33. (s)-2-[[4-(2-fluorobenzyloxy)benzyl]amino]propanamide

    34. 2-(((4-((2-fluorophenyl)methoxy)phenyl)methyl)amino)propanamide

    35. Us9051240, (s)-(+)-2-[4-(2-fluorobenzyloxy)-benzylamino]-propanamide

    2.4 Create Date
    2005-08-09
    3 Chemical and Physical Properties
    Molecular Weight 302.34 g/mol
    Molecular Formula C17H19FN2O2
    XLogP32.2
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count7
    Exact Mass302.14305602 g/mol
    Monoisotopic Mass302.14305602 g/mol
    Topological Polar Surface Area64.4 Ų
    Heavy Atom Count22
    Formal Charge0
    Complexity346
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in pain (acute or chronic).